human nav1.7 ion channel cell line (SB Drug Discovery)
90
Structured Review
SB Drug Discovery
human nav1.7 ion channel cell line
Human Nav1.7 Ion Channel Cell Line, supplied by SB Drug Discovery, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nav1%2E7+ion+channel+cell+line/hek+hnav1+7+stable+cell+line/pmc05799132-60-54-62
Average 90 stars, based on 1 article reviews
Human Nav1.7 Ion Channel Cell Line, supplied by SB Drug Discovery, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+nav1%2E7+ion+channel+cell+line/hek+hnav1+7+stable+cell+line/pmc05799132-60-54-62
Average 90 stars, based on 1 article reviews
human nav1.7 ion channel cell line - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Modification:Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: Reagents The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the Produced:Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: Reagents The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the Sequencing:Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: Reagents The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the Control:Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the Article Title: Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 Article Snippet: Reagents The hollow fiber bioreactor was from Fiber Cell Systems Inc. (MD); Dulbecco’s modified Eagle’s medium (DMEM) was from Gibco or Sigma; penicillin-streptomycin was from Gibco; rSVmab was produced by Genscript Co., according to the published sequence of SVmab and using the isotype of IgG1; control mouse IgG was from Santa Cruz Biochem; the |